ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Adrenal Endocrinology
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1597908
Sex differences in management and outcomes in pheochromocytomas and paragangliomas
Provisionally accepted
- 1Karolinska Institutet (KI), Solna, Sweden
- 2Department of Endocrinology, Metabolism and Diabetes, Karolinska University Hospital, Stockholm, Stockholm, Sweden
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
The aim of this study was to investigate sex differences in the management and outcomes of patients with pheochromocytomas and paragangliomas (PPGLs).Methods: This is a retrospective cohort study including all patients diagnosed with PPGLs attending the Department of Endocrinology at Karolinska University Hospital between June 2005 and August 2024. The collected data included patient characteristics, biochemical, genetical, pharmacological and vital parameters noted during initial PPGL presentation and during follow-up, including survival.In total, 196 patients diagnosed with PPGLs (108 females and 88 males) were included. Paragangliomas were more prevalent in females than in males (23.1% vs 11.4%, P=0.04). Females required a lower final dose of preoperative phenoxybenzamine (50.8±19.8 vs 87.5±75.7 mg, P=0.04), while the final dose of preoperative doxazosin was non-significant lower (22.3±13.6 vs 26.0±13.9 mg, P=0.07). Moreover, females were less likely having laparoscopic surgery than males (55.2% vs 71.1%, P=0.03). After surgery, more females achieved remission from their type 2 diabetes compared to males (23.44.1% vs 11.81.4%, P=0.043). Despite similar age at diagnosis and similar follow-up time, no sex differences were identified in metastasis risk, blood pressure outcomes after surgery, or survival.Females presented more often with paragangliomas which may explain why they were less likely to have laparoscopic surgery. Remission of type 2 diabetes occurred more commonly in females after surgery. Most other outcomes were similar between sexes. More research is needed to explore differences in outcomes between sexes in PPGLs.
Keywords: PPGL, gender, diabetes, Hypertension, Survival, adrenal medullary tumor
Received: 21 Mar 2025; Accepted: 27 May 2025.
Copyright: © 2025 Dahl, Calissendorff and Falhammar. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Måns Axel Jesper Dahl, Karolinska Institutet (KI), Solna, Sweden
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.